Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has removed a detailed section regarding data download options and fields related to clinical study information.SummaryDifference14%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.SummaryDifference16%
- Check38 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check45 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
- Check67 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.